High-Throughput Target Screening Service for Pet Antibody Discovery

Are you currently facing challenges in identifying viable therapeutic targets for companion animal diseases, extended discovery timelines, or difficulties in validating potential targets? Creative Biolabs' high-throughput target screening service helps you accelerate the identification and validation of novel therapeutic targets for pet antibody development through advanced high-throughput screening platforms, comprehensive and species-relevant target libraries, and proprietary data analysis pipelines designed specifically for veterinary medicine.

High-Throughput Antibody Target Screening Service Introduction

HTS Antibody Target Screening (Creative Biolabs Authorized)

High-throughput screening (HTS) addresses this challenge by enabling the rapid, parallel evaluation of thousands of potential targets. As supported by recent advancements, modern HTS technologies, including functional genomics and automated cellular imaging, allow for more efficient and biologically relevant discovery, significantly accelerating the pipeline for novel pet antibody drugs. Creative Biolabs provides a comprehensive, end-to-end solution to pinpoint the most promising therapeutic targets for your veterinary antibody discovery programs. Our service is designed to move your project from a broad biological question to a focused list of validated, druggable targets with speed and precision. We deliver not just raw data, but actionable biological insights. You will receive a ranked list of validated target candidates, complete with comprehensive data packages for each, and detailed analysis of their involvement in relevant biological pathways. This enables you to make data-driven decisions and confidently advance the most promising candidates into your development pipeline.

Request a Consultation

Workflow of High-Throughput Antibody Target Screening

Our workflow is a systematic, multi-stage process designed for maximum efficiency and data integrity, ensuring a clear path from project initiation to the delivery of validated targets.

Fig. 1 HTS Pet Antibody Target Discovery Workflow. (Creative Biolabs Original)

1. Project Consultation & Assay Development	We begin with an in-depth consultation to define project goals and the biological question. Our scientists then collaborate with you to develop or optimize a robust, HTS-compatible screening assay (e.g., cell viability, reporter gene, or high-content imaging) tailored to your specific veterinary disease model.
2. High-Throughput Library Screening	The validated assay is then used to screen against our extensive and diverse libraries, which can include genome-wide siRNA, shRNA, or cDNA/ORF collections relevant to canine and feline genetics. This primary screen rapidly identifies initial "hits" that modulate the biological phenotype of interest.
3. Bioinformatic Analysis	Our bioinformatics team performs in-depth data analysis, including pathway and network analysis, to place the validated targets within a biological context. This process helps to prioritize targets based on their potential efficacy and druggability.
4. Final Reporting	Upon project completion, you'll receive a comprehensive data package. This includes a detailed report of our methodology, raw and analyzed data, and a prioritized list of validated therapeutic targets. These targets are ranked by biological rationale, druggability, predicted safety, and novelty, along with a full bioinformatics report.

Why Choose Us?

Specialized Veterinary Focus
Unlike generalist service providers, our platforms, libraries (e.g., siRNA, cDNA), and scientific expertise are specifically tailored for companion animal biology, addressing the unique genetic and physiological aspects of canine and feline diseases.
Advanced Multi-Platform Technology
We utilize a suite of diverse HTS platforms, enabling us to select the optimal screening approach—whether it's functional genomics, expression-based screening (cDNA/ORF), or other modalities—to best suit your target class and biological question.
Robust Data Analysis and Interpretation
Our service is powered by a sophisticated bioinformatics pipeline designed to meticulously analyze complex screening data. This process effectively minimizes false positives and provides deep biological context, translating raw hits into actionable, pathway-linked targets.

FAQs

1. What types of targets can your HTS service identify for pet diseases?

Our platforms are versatile and can identify a wide range of target classes, including cell surface receptors, enzymes (like kinases and proteases), ion channels, and other proteins involved in disease signaling pathways. We tailor the screening strategy to the target class most relevant to your therapeutic goals.

2. How does your HTS platform differ from traditional, lower-throughput methods for target discovery?

The primary advantages are speed, scale, and data density. While traditional methods test a handful of hypotheses, HTS allows for an unbiased, genome-wide or library-wide search, uncovering novel and unexpected targets. This massively parallel approach drastically reduces the discovery timeline from years to weeks and provides a much richer dataset for decision-making.

3. After you identify a target, what are the next steps, and can Creative Biolabs assist with them?

Once we deliver the validated target report, the next step is typically to develop therapeutic antibodies against that target. As an end-to-end service provider, Creative Biolabs is fully equipped to assist. We recommend exploring our pet antibody discovery services to seamlessly continue your project's journey.

Related Services

To further bolster your therapeutic development, Creative Biolabs provides a suite of complementary services that seamlessly integrate with our target screening solutions.

Genomic Solution

Explore genetic drivers of disease with our veterinary-focused DNA sequencing and analysis services.

Transcriptomics Solution

Understand gene expression changes in your disease model with our comprehensive RNA-Seq and data analysis services.

Proteomic Solution

Quantify protein expression and identify post-translational modifications with our advanced mass spectrometry platforms.

In Silico Target Screening

Leverage computational biology to pre-screen and prioritize target lists before committing to laboratory-based screening.

Partner with Creative Biolabs

Creative Biolabs is dedicated to accelerating the next generation of pet therapeutics. Our high-throughput pet antibody target screening service provides the critical first step—delivering high-confidence, validated targets that form the foundation of a successful antibody discovery program. We combine cutting-edge technology with deep biological expertise to ensure your project is positioned for success.

Ready to identify your next therapeutic target? Our team of specialists is available to discuss your project requirements and design a screening strategy that meets your specific needs. Please contact us for more information and discuss your pet therapeutic antibody discovery project.

Contact Our Team

Services